Abstract:Background: Numerous studies have demonstrated the influence of gut microbiota on the development of obesity. In this study, we utilized Mendelian randomization (MR) analysis to investigate the gut microbiota characteristics among different types of obese patients, aiming to elucidate the underlying mechanisms and provide novel insights for obesity treatment. Methods: Two-sample multivariable Mendelian randomization (MR) analysis was employed to assess causal relationships between gut microbiota and various obesity subtypes. Gut microbiota data were obtained from the international consortium MiBioGen, and data on obese individuals were sourced from the Finnish National Biobank FinnGen. Eligible single-nucleotide polymorphisms (SNPs) were selected as instrumental variables. Various analytical methods, including inverse variance weighted (IVW), MR-Egger regression, weighted median, MR-RAPS, and Lasso regression, were applied. Sensitivity analyses for quality control included MR-Egger intercept tests, Cochran's Q tests, and leave-one-out analyses and others. Results: Mendelian randomization studies revealed distinct gut microbiota profiles among European populations with different obesity subtypes. Following multivariable MR analysis, we found that Ruminococcaceae UCG010 [ Odds Ratio (OR) : 0.842, 95% confidence interval (CI) : 0.766-0.926, Adjusted P value: 0.028] independently reduced the risk of obesity induced by excessive calorie intake, while Butyricimonas [ OR : 4.252, 95% CI : 2.177-8.307, Adjusted P value: 0.002] independently increased the risk of medication-induced obesity. For localized adiposity, Pasteurellaceae [ OR : 0.213, 95% CI : 0.115-0.395, Adjusted P value: <0.001] acted as a protective factor. In the case of extreme obesity with alveolar hypoventilation, lactobacillus [ OR : 0.724, 95% CI : 0.609-0.860, Adjusted P value: 0.035] reduced the risk of its occurrence. Additionally, six gut microbiota may have potential roles in the onset of different types of obesity. Specifically, the Ruminococcus torques group may increase the risk of its occurrence. Desulfovibrio and Catenabacterium may serve as protective factors in the onset of Drug-induced obesity. Oxalobacteraceae , Actinomycetaceae , and Ruminiclostridium 9 , on the other hand, could potentially increase the risk of Drug-induced obesity. No evidence of heterogeneity or horizontal pleiotropy among SNPs was found in the above studies (all P values for Q test and MR-Egger intercept > 0.05). Conclusion: Gut microbiota abundance is causally related to obesity, with distinct gut microbiota profiles observed among different obesity subtypes. Four bacterial species, including Ruminococcaceae UCG010 , Butyricimonas , Pasteurellaceae and lactobacillus independently influence the development of various types of obesity. Probiotic and prebiotic supplementation may represent a novel approach in future obesity management.

Gut microbiota affects obesity susceptibility in mice through gut metabolites

High-fat-diet-induced gut microbiome changes in mice

Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet

Metabolic and Gut Microbial Characterization of Obesity-Prone Mice under a High-Fat Diet

The Role of Gut Microbiota in the Resistance to Obesity in Mice Fed a High Fat Diet

Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity

Alteration of gut microbiota affects expression of adiponectin and resistin through modifying DNA methylation in high-fat diet-induced obese mice

Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids

High-fat Feeding Rather Than Obesity Drives Taxonomical and Functional Changes in the Gut Microbiota in Mice

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility

Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice

Gut Microbiota Characteristics of People with Obesity by Meta-Analysis of Existing Datasets

In‐depth multiomic characterization of the effects of obesity in high‐fat diet‐fed mice

Unraveling the mystery: a Mendelian randomized exploration of gut microbiota and different types of obesity

An obesity-associated gut microbiome with increased capacity for energy harvest

Mendelian Randomization Analysis Reveals Causal Effects Of The Human Gut Microbiota On Abdominal Obesity

Antibiotics-induced Perturbations in Gut Microbial Diversity Influence Metabolic Phenotypes in a Murine Model of High-Fat Diet-Induced Obesity

IL-17A-dependent Gut Microbiota is Essential for Regulating Diet-Induced Disorders in Mice

Integrated omics analysis reveals the alteration of gut microbe-metabolites in obese adults

High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity

Gut Microbiota Dysbiosis Ameliorates in LNK-Deficient Mouse Models with Obesity-Induced Insulin Resistance Improvement